ACM
CYTK icon

Aster Capital Management’s Cytokinetics CYTK Stock Holding History

Aster Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-811
Closed -$44.6K – 1164
2025
Q3 		$44.6K Buy
+811
New +$33.4K 0.02% 517

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Aster Capital Management's CYTK Position: Q4 2025 in Review

Aster Capital Management sold out of Cytokinetics (CYTK) in Q4 2025, closing a stake of 811 shares — an estimated $44.6K sold.

Aster Capital Management first reported a position in CYTK in Q3 2025 and held it in 1 quarter. The position peaked at $44.6K in Q3 2025. 430 funds tracked by Wall St. Rank hold CYTK as of Q4 2025.

  • Aster Capital Management reported no remaining Cytokinetics position as of Q4 2025 after selling out during the quarter.
  • Aster Capital Management sold 811 Cytokinetics shares in Q4 2025, an estimated $44.6K.
  • Aster Capital Management first reported a position in Cytokinetics in Q3 2025 and held it in 1 quarter.
  • Aster Capital Management's Cytokinetics position peaked at $44.6K in Q3 2025.
  • 430 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2025.

Based on Aster Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.